Multiple-endpoint genotoxicity assay for colon carcinogen 1,2-dimethylhydrazine

Area of Science:

• Toxicology
• Genetics
• Risk Assessment

Background:

• Chemical risk assessment relies on genotoxicity assays to predict carcinogenicity.
• Animal welfare concerns (3Rs) necessitate reducing experimental animal numbers in genotoxicity testing.
• Combining multiple genotoxicity assays in single animals is a strategy to reduce animal use.

Purpose of the Study:

• To simultaneously assess gene mutation frequency and chromosomal aberration in vivo.
• To evaluate the utility of combining assays for reducing animal use in genotoxicity testing.
• To investigate the genotoxic mechanism of a colon carcinogen using a reduced animal model.

Main Methods:

• Used 1,2-dimethylhydrazine as a model colon carcinogen in F344 gpt delta transgenic rats.
• Combined a gene mutation frequency assay with a multiple-organ micronucleus test (peripheral blood, bone marrow, liver, colon).
• Assessed gpt mutant frequency and micronucleated cell frequency in various tissues.

Main Results:

• Significant increases in gpt mutant frequency and micronucleated cell frequency were observed in the colon and liver, but not bone marrow.
• The colon carcinogen induced both gene mutations and micronuclei in the targeted colon tissue.
• Increased mutant frequency was detected as early as day 1 and day 3 post-treatment, aligning with guideline recommendations.

Conclusions:

• Simultaneous evaluation of gene mutation and micronucleus endpoints in F344 gpt delta transgenic rats effectively reduces the number of experimental animals.
• This combined approach allows for the derivation of carcinogen mechanisms from in vivo experiments with fewer animals.
• The study demonstrates the feasibility and utility of integrated genotoxicity testing for efficient and ethical chemical risk assessment.